(a)
To determine: Whether the conclusion, “Bellicose can be
Introduction: A bacteria Hokus focus codes for enzymes bellicose kinase and bellicose phosphate through the genes belA and belB. Two classes of mutants were identified by Professor Jean X. Pression. These two classes were class I which has a mutation in cis-acting elements and class II in which all map at a distance from the genes encoding the enzymes.
(b)
To determine: Whether the conclusion, “Enzyme production by genes belA and bell are under positive control.” is consistent with the data (C), inconsistent with the data (I) or irrelevant to the data (X).
Introduction: A bacteria Hokus focus codes for enzymes bellicose kinase and bellicose phosphate through the genes belA and belB. Two classes of mutants were identified by Professor Jean X. Pression. These two classes were class I which has a mutation in cis-acting elements and class II in which all map at a distance from the genes encoding the enzymes.
(c)
To determine: Whether the conclusion, “Phosphorylation of bellicose makes the sugar less permeable to transport across the plasma membrane.” is consistent with the data (C), inconsistent with the data (I) or irrelevant to the data (X).
Introduction: A bacteria Hokus focus codes for enzymes bellicose kinase and bellicose phosphate through the genes belA and belB. Two classes of mutants were identified by Professor Jean X. Pression. These two classes were class I which has a mutation in cis-acting elements and class II in which all map at a distance from the genes encoding the enzymes.
(d)
To determine: Whether the conclusion, “The operator for bellicose operon is located upstream from the promoter.” is consistent with the data (C), inconsistent with the data (I) or irrelevant to the data (X).
Introduction: A bacteria Hokus focus codes for enzymes bellicose kinase and bellicose phosphate through the genes belA and belB. Two classes of mutants were identified by Professor Jean X. Pression. These two classes were class I which has a mutation in cis-acting elements and class II in which all map at a distance from the genes encoding the enzymes.
(e)
To determine: Whether the conclusion, “Some of the mutations in class I may be in the promoter.” is consistent with the data (C), inconsistent with the data (I) or irrelevant to the data (X).
Introduction: A bacteria Hokus focus codes for enzymes bellicose kinase and bellicose phosphate through the genes belA and belB. Two classes of mutants were identified by Professor Jean X. Pression. These two classes were class I which has a mutation in cis-acting elements and class II in which all map at a distance from the genes encoding the enzymes.
(f)
To determine: Whether the conclusion, “Some of the mutations in class II may be in the promoter.” is consistent with the data (C), inconsistent with the data (I) or irrelevant to the data (X).
Introduction: A bacteria Hokus focus codes for enzymes bellicose kinase and bellicose phosphate through the genes belA and belB. Two classes of mutants were identified by Professor Jean X. Pression. These two classes were class I which has mutation in cis-acting elements and class II in which all map at a distance from the genes encoding the enzymes.
(g)
To determine: Whether the conclusion, “Class II mutations may include mutations in the gene that encodes CAP.” is consistent with the data (C), inconsistent with the data (I) or irrelevant to the data (X).
Introduction: A bacteria Hokus focus codes for enzymes bellicose kinase and bellicose phosphate through the genes belA and belB. Two classes of mutants were identified by Professor Jean X. Pression. These two classes were class I which has mutation in cis-acting elements and class II in which all map at a distance from the genes encoding the enzymes.
(h)
To determine: Whether the conclusion, “The constitutive deletion mutations connect genes belA and belB to a new promoter.” is consistent with the data (C), inconsistent with the data (I) or irrelevant to the data (X).
Introduction: A bacteria Hokus focus codes for enzymes bellicose kinase and bellicose phosphate through the genes belA and belB. Two classes of mutants were identified by Professor Jean X. Pression. These two classes were class I which has a mutation in cis-acting elements and class II in which all map at a distance from the genes encoding the enzymes.
(i)
To determine: Whether the conclusion, “Expression of the bellicose operon is subject to regulation by attenuation.” is consistent with the data (C), inconsistent with the data (I) or irrelevant to the data (X).
Introduction: A bacteria Hokus focus codes for enzymes bellicose kinase and bellicose phosphate through the genes belA and belB. Two classes of mutants were identified by Professor Jean X. Pression. These two classes were class I which has a mutation in cis-acting elements and class II in which all map at a distance from the genes encoding the enzymes.
Want to see the full answer?
Check out a sample textbook solutionChapter 20 Solutions
Becker's World of the Cell (9th Edition)
- Serine protease enzyme mutation To show differences in the effect of the nucleophilic attack of the carbonyl group (C=O) of peptide bond between the catalytic triad of serine, histidine and aspartic acid, and another catalytic triad contains alanine, histidine and aspartic acid Provide/ draw an example of catalytic mechanism with catalytic triad contains alanine, histidine and aspartic Please answer completely will give rating surelyarrow_forwardBIOMOLECULES - MULTIPLE CHOICE - Please answer properly QUESTION : In human beings, what is the major control of de novo pyrimidine nucleotide synthesis? A. substrate availability B. competitive inhibition of carbamoyl phosphate synthetase II C. feedback inhibition of glutamine-PRPP amidotransferase D. vailability of N-acetyl glutamatearrow_forwardQuestion:- Explain why it makes sense for the PDH complex in liver to be active when dephosphorylated.arrow_forward
- Enzyme: Crystal Structure of Wild-Type Human Phosphoglucomutase-1 (PGM1) the description of the mechanism of how this enzyme is regulated (e.g., depending on the enzyme, the mechanism could range from being solely dependent on gene regulation to protein structure-based mechanism).arrow_forwardMolecular detail of spike Y453Farrow_forwardIDENTIFICATION. One of the B-complex vitamins which is the precursor of Nicotinamide in the coenzyme NAD+. Carrier of the activated amino acids to the ribosomes for incorporation into the growing peptide chain. Molecule that attaches to myosin and actin during muscle contraction.arrow_forward
- Question:- Explain why withholding galactose from the diet of galactosaemia patients has no effects on their synthesis of glycoprotein.arrow_forwardPlz answer correctly do not copy. Question- Arsinate binds to reduced thio groups such as those found in cystiene residues in proteins, lipoate or glutathione. The resulting inhibition leads to central nervous system pathologies. The binding of arsinate to the dihydrolipoyl groups inhibits which of the following enzyme(s)? succinate dehydrogenase malate dehydrogenase pyruvate dehydrogenase complex branched-chain amino acid dehydrogenase complex isocitrate dehydrogenase alpha-ketoglutarate dehydrogenase complexarrow_forwardExponential expansion? Compare the amount of information inherent in the genome, the proteome, and the glycome.arrow_forward
- Protein folding with PDI and Peptidyl-prolyl isomerasearrow_forwardSuggest a reason why the cell membrane of bacteria grown at 20oC tend to have a higher proportion of unsaturated fatty acids than the membranes of bacteria of the same species grown at 37oC.arrow_forwardBIOMOLECULES - Please answer the questions properly. - Multiple choice 1. In human beings, what is the major control of de novo pyrimidine nucleotide synthesis? A. substrate availability B. feedback inhibition of glutamine-PRPP amidotransferase C. competitive inhibition of carbamoyl phosphate synthetase II D. availability of N-acetyl glutamate 2. In patients with Lesch Nyhan Syndrome, purine nucleotides are overproduced and over excreted. The hypoxanthine analogue Allopurinol, which effectively treats gout , has no effect on the severe neurological symptoms of Lesch- Nyhan patients because it does not? A. decrease de novo pyrimidine synthesis B. increase PRPP levels (Phosphoribosyl pyrophosphate) C. Decrease urate synthesis D. decrease de novo purine synthesisarrow_forward
- BiochemistryBiochemistryISBN:9781305577206Author:Reginald H. Garrett, Charles M. GrishamPublisher:Cengage Learning